Novel allosteric inhibitors of HIV-1 integrase on the base of multimodified oligonucleotides

被引：0
|
作者：
Zatsepin, T. [1 ]
Korolev, S. [1 ]
Smolov, M. [1 ]
Gottikh, M. [2 ]
Agapkina, J. [1 ]
机构：
[1] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia
[2] Moscow MV Lomonosov State Univ, Belozersky Inst Phys & Chem Biol, Moscow, Russia
来源：
FEBS JOURNAL | 2010年 / 277卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors
    Wilson, Tyler A.
    Koneru, Pratibha C.
    Rebensburg, Stephanie V.
    Lindenberger, Jared J.
    Kobe, Matthew J.
    Cockroft, Nicholas T.
    Adu-Arnpratwum, Daniel
    Larue, Ross C.
    Kvaratskhelia, Mamuka
    Fuchs, James R.
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (02): : 215 - 220
  • [2] Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors
    Jurado, Kellie Ann
    Engelman, Alan
    [J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2013, 15
  • [3] Indole-based allosteric inhibitors of HIV-1 integrase
    Patel, Pratiq A.
    Kvaratskhelia, Nina
    Mansour, Yara
    Antwi, Janet
    Feng, Lei
    Koneru, Pratibha
    Kobe, Mathew J.
    Jena, Nivedita
    Shi, Guqin
    Mohamed, Mosaad S.
    Li, Chenglong
    Kessl, Jacques J.
    Fuchs, James R.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4748 - 4752
  • [4] Design and synthesis of novel and potent allosteric HIV-1 integrase inhibitors with a spirocyclic moiety
    Adachi, Kaoru
    Manabe, Tomoyuki
    Yamasaki, Takayuki
    Suma, Akira
    Orita, Takuya
    Furuzono, Tomoko
    Adachi, Tsuyoshi
    Ohata, Yoshitsugu
    Akiyama, Yoshiyuki
    Miyazaki, Susumu
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 110
  • [5] Discovery of novel HIV-1 integrase inhibitors
    Hong, HX
    Neamati, N
    Wang, SM
    Nicklaus, M
    Pommier, Y
    Milne, GWA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 22 - MEDI
  • [6] The LEDGINs: first-in-class allosteric HIV-1 integrase inhibitors
    Desimmie, B.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 14 - 14
  • [7] Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors
    Kessl, Jacques J.
    Jena, Nivedita
    Koh, Yasuhiro
    Taskent-Sezgin, Humeyra
    Slaughter, Alison
    Feng, Lei
    de Silva, Suresh
    Wu, Li
    Le Grice, Stuart F. J.
    Engelman, Alan
    Fuchs, James R.
    Kvaratskhelia, Mamuka
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (20) : 16801 - 16811
  • [8] Elaboration of indole frameworks in the development of allosteric HIV-1 integrase inhibitors
    Antwi, Janet
    Koneru, Pratibha
    Kobe, Matt
    Kvaratskhelia, Mamuka
    Fuchs, James
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [9] Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
    Li, Guo
    Meanwell, Nicholas A.
    Krystal, Mark R.
    Langley, David R.
    Naidu, B. Narasimhulu
    Sivaprakasam, Prasanna
    Lewis, Hal
    Kish, Kevin
    Khan, Javed A.
    Ng, Alicia
    Trainor, George L.
    Cianci, Christopher
    Dicker, Ira B.
    Walker, Michael A.
    Lin, Zeyu
    Protack, Tricia
    Discotto, Linda
    Jenkins, Susan
    Gerritz, Samuel W.
    Pendri, Annapurna
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (05) : 2620 - 2637
  • [10] Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors
    Long Phi Dinh
    Sun, Jian
    Glenn, Courtney D.
    Patel, Krunal
    Pigza, Julie A.
    Donahue, Matthew G.
    Yet, Larry
    Kessl, Jacques J.
    [J]. VIRUSES-BASEL, 2022, 14 (07):
12345